J&J raises 2026 outlook as oncology products power Q1 beat

Seeking Alpha — Apr 14, 10:50 AM

Read full article at Seeking Alpha →

J&J beats Q1 estimates

• J&J’s first-quarter profit beats estimates even as Stelara sales disappoint CTV News — Apr 14, 11:55 AM
• J&J’s First-Quarter Sales Grow on Cancer-Drug Strength Wall Street Journal — Apr 14, 10:20 AM
• J&J’s first-quarter profit beats estimates even as Stelara sales disappoint The Globe and Mail — Apr 14, 11:28 AM
• Johnson & Johnson Non-GAAP EPS of $2.70 beats by $0.02, revenue of $24.06B beats by $450M Seeking Alpha — Apr 14, 10:21 AM
• Earnings Snapshot: Johnson & Johnson tops Q1 expectations; boosts full-year outlook and increases quarterly dividend Seeking Alpha — Apr 14, 10:52 AM